(-0.14%) 5 461.41 points
(-0.11%) 39 071 points
(0.10%) 17 736 points
(-0.67%) $80.29
(-4.32%) $2.64
(-0.77%) $2 312.90
(0.15%) $28.91
(2.36%) $1 009.70
(0.31%) $0.936
(0.74%) $10.68
(0.48%) $0.792
(-0.13%) $87.38
Live Chart Being Loaded With Signals
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies...
Stats | |
---|---|
Today's Volume | 56 809 |
Average Volume | 0 |
Market Cap | 14.47M |
EPS | $-0.520 ( Q1 | 2024-05-13 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.491 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.147 (7.50%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-07-18 | Le Goff Corinne | Buy | 177 000 | Stock Option (Right to Buy) |
2022-07-18 | Le Goff Corinne | Sell | 0 | Common Stock |
2022-06-13 | Kardaras Constantine John | Buy | 1 750 | Option to Purchase Celsion Common Stock |
2022-06-13 | Tumminello Timothy J | Buy | 7 500 | Option to Purchase Celsion Common Stock |
2022-06-13 | Chow Pok Yu Augustine | Buy | 7 500 | Option to Purchase Celsion Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 4 307 000 | Sell: 1 490 000 |
Volume Correlation
Imunon, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Imunon, Inc. Correlation - Currency/Commodity
Imunon, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-720 005 (0.00 %) |
EPS: | $-2.16 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-720 005 (0.00 %) |
EPS: | $-2.16 |
FY | 2022 |
Revenue: | $500 000 |
Gross Profit: | $-231 629 (-46.33 %) |
EPS: | $-5.03 |
FY | 2021 |
Revenue: | $500 000 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.83 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Imunon, Inc.
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators